(1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol

• ChemBase ID: 72803
• Molecular Formular: C21H32N2O
• Molecular Mass: 328.49158
• Monoisotopic Mass: 328.25146365
• SMILES: c12c(C[C@H]3[C@](C1)([C@@H]1[C@@H](CC3)[C@H]3[C@](CC1)([C@](CC3)(O)C)C)C)[nH]nc2
• Canonical SMILES: C[C@]12Cc3cn[nH]c3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@]2(C)O)C
• InChI: InChI=1S/C21H32N2O/c1-19-11-13-12-22-23-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,24H,4-11H2,1-3H3,(H,22,23)/t14-,15+,16-,17-,19-,20-,21-/m0/s1
• InChIKey: LKAJKIOFIWVMDJ-IYRCEVNGSA-N

NAMES AND DATABASE IDS

Names

• IUPAC name: (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.0^2,^1^0.0^4,^8.0^1^4,^1^8]icosa-4(8),5-dien-17-ol; (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.0^2,^1^0.0^4,^8.0^1^4,^1^8]icosa-4,7-dien-17-ol; (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.0^{2,10}.0^{4,8}.0^{14,18}]icosa-4(8),5-dien-17-ol
• IUPAC Traditional name: stanozolol
• Synonyms: Stanozolol; Winstrol; Winstrol Depot; Stanozolol; (5α,17β)-17-Methyl-2'H-androst-2-eno[3,2-c]pyrazol-17-ol; 17-Methyl-5α-androstano[3,2-c]pyrazol-17β-ol; Anabol; Androstanazol; Androstanazole; Androstanazolestanazol; Estazol; NSC 233046; Stanazolol; Strombaject; Tevabolin; Win 14833; Winstroid; 17β-羟基-17α-甲基-5α-雄甾烷基[3,2-c]吡唑; 5α-雄烷-17α-甲基-17β-醇-[3,2-c]吡唑; 吡唑甲氢龙; 康力龙; 司坦唑醇

Database IDs

• CAS Number: 10418-03-8
• EC Number: 233-894-8
• MDL Number: MFCD00133084
• PubChem SID: 162037724; 24899733
• PubChem CID: 25249
• ATC CODE: A14AA02
• CHEMBL: 1200324
• Chemspider ID: 23582
• DrugBank ID: DB06718
• KEGG ID: D00444
• Unique Ingredient Identifier: 4R1VB9P8V3
• Wikipedia Title: Stanozolol

CALCULATED PROPERTIES

• Acid pKa: 15.504109
• H Acceptors: 2
• H Donor: 2
• LogD (pH = 5.5): 3.6970553
• LogD (pH = 7.4): 3.6974132
• Log P: 3.6974177
• Molar Refractivity: 97.253 cm^3
• Polarizability: 37.832325 Å^3
• Polar Surface Area: 48.91 Å^2
• Rotatable Bonds: 0
• Lipinski's Rule of Five: true

PROPERTIES

Physical Property

• Solubility: Chloroform; Methanol
• Apperance: White Solid; white to light yellow powder
• Melting Point: 214-216°C

Safety Information

• Storage Condition: -20°C; Controlled Substance, -20°C Freezer
• RTECS: BV8741000
• European Hazard Symbols: Harmful (Xn)
• German water hazard class: 3
• Risk Statements: 63
• Safety Statements: 53-22-36/37/39
• GHS Pictograms: GHS08
• GHS Signal Word: Warning
• GHS Hazard statements: H361
• GHS Precautionary statements: P281
• Personal Protective Equipment: Eyeshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges
• Drug Control: USDEA Schedule III; Home Office Schedule 4.2; regulated under CDSA - not available from Sigma-Aldrich Canada
• Storage Temperature: 2-8°C

Pharmacology Properties

• Admin Routes: Oral, Intramuscular
• Excretion: Renal: 84%
• Half Life: 1 day
• Metabolism: Hepatic
• Legal Status: Prescription only ; (US)
• Pregnancy Category: X

Product Information

• Grade: analytical standard, for drug analysis
• Salt Data: Free Base

DETAILS

Selleck Chemicals - S1788

Related research area: Endocrinology

Toronto Research Chemicals - S684500

Anabolic steroid. Androgen.Controlled substance.

REFERENCES

• http://en.wikipedia.org/wiki/Stanozolol
• Gradeen, C., et al.: J. Anal. Toxicol., 14, 120 (1990)
• Schanzer, W., et al.: J. Steroid Biochem., 36, 153 (1990)
• Yamada, M., et al.: J. Pharm. Biomed. Anal., 45, 125 (1990)